Technology can be used to make it easier for patients and practices to participate in clinical trials, while also easing some of the burden on research staff, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.
Technology can be used to make it easier for patients and practices to participate in clinical trials, while also easing some of the burden on research staff, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.
Transcript
How is technology making it a little easier to enroll patients in clinical trials and manage these trials?
I think of technology as a tool that can make clinical trials a little bit less disruptive to the clinical workflow and a little bit less burdensome on the research staff. So an example: if you can design within your electronic medical record, a way that you can capture disease factors—think biomarkers, like EGFR or ROS or ALK in lung cancer—if you can capture those in structured data fields, then you can start to use that as a filter for screening patients for the trial. That makes the work of the research team significantly easier, because they don’t have to go through every patient who comes to the practice.
It also increases your hit rate, so you’re less likely to miss patients who are coming through your doors that could be a candidate for a trial if you have that automated safety net running in the background.
In addition, I think there’s a huge opportunity for technology to change the way we capture data in clinical trials. So, most trials, right now, there’s a duplicative data entry process. The patient comes in and is seen, there clinical care is documented as it normally would be, and then a research staff member has to go into an electronic data capture (EDC) format and reenter the data. Dual data entry is obviously burdensome and time consuming and slows things down. If you can have the EHR directly populate the EDC that would be transformative in getting really high-quality data in a really timely manner, which is what sponsors are looking for.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More